Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04042883
Other study ID # Hemodilution off-pump CABG
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date August 10, 2019
Est. completion date April 15, 2020

Study information

Verified date August 2019
Source Assiut University
Contact Hany M. Osman, M.D.
Phone +201002414591
Email hanymeo@aun.edu.eg
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

To study the effects of Acute normovolemic hemodilution on central and peripheral perfusion in patients Undergoing off-pump coronary artery bypass grafting surgery


Description:

Off‑pump coronary artery bypass surgery is an alternative to conventional coronary artery bypass grafting using cardiopulmonary bypass (CPB). It avoids adverse effects of CPB such as systemic inflammatory response, impaired myocardial protection, and air or plaque embolism. However, OPCAB surgery involves displacement and manipulation of the heart to expose target coronary arteries. These manipulations cause hemodynamic instability as a result of transient annulo‑mitral distortion and acute mitral regurgitation, compression of the right ventricle, and impaired cardiac contractility due to epicardial stabilizers. signs of impaired perfusion such as metabolic acidosis, increased serum lactate and decreased urine output are commonly seen intraoperatively

Excessive surgical bleeding causes hypovolemia and hemodynamic instability, anemia, and reduced oxygen delivery to tissues

Acute normovolemic hemodilution (ANH) is an alternative method of management of intraoperative blood loss, in which a certain volume of blood is collected from the patient, stored at room temperature and replaced by an equal volume of colloid solution. By the end of surgery, this blood is returned to the patient, usually within eight hours of collection, with little deterioration of platelets or coagulation factors

This work aims to study the effects of Acute normovolemic hemodilution on central and peripheral perfusion in patients Undergoing off-pump coronary artery bypass grafting surgery


Recruitment information / eligibility

Status Recruiting
Enrollment 50
Est. completion date April 15, 2020
Est. primary completion date April 15, 2020
Accepts healthy volunteers No
Gender All
Age group 40 Years to 80 Years
Eligibility Inclusion Criteria:

- Patients scheduled for off- pump CABG surgery

Exclusion Criteria:

- Ejection fraction less than 40%

- Hematocrit less than 11 g/dl

- patients with severe renal impairment

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Acute normovolemic hemodilution
500 ml of blood will be taken from the patient with simultaneous replacement with hydroxyethyl starch (HES 130/0.4) in another IV line

Locations

Country Name City State
Egypt Assiut University Assiut

Sponsors (1)

Lead Sponsor Collaborator
Assiut University

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary Central venous oxygen saturation Central venous blood gas analysis Intraoperative
Primary The perfusion index perfusion index derived from pulseoximetry Intraoperative
Primary Serum lactate from arterial blood gas analysis Intraoperative
See also
  Status Clinical Trial Phase
Completed NCT04369443 - Application of Large Volume Acute Normovolemic Hemodilution in Cardiac Surgery N/A
Recruiting NCT06459141 - The Effect of Hemodilution on Intraoperative Allogeneic Transfusion (HEAL) N/A